Skip to main content
. 2023 Apr 28;13:1143600. doi: 10.3389/fonc.2023.1143600

Figure 2.

Figure 2

Representative figures of 3D bioprinted hepato-pancreato-biliary (HPB) cancer models. (A) The design of a 3D bioprinted hepatocellular carcinoma (HCC) model combined with microfluidic technology; adapted with permission (30), copyright 2019 IOP Publishing. (B) A 3D bioprinted model with cholangiocarcinoma (CCA) cells and stromal cells; adapted with permission (65), copyright 2022 Frontiers. (C) A 3D bioprinted pancreatic cancer model for high-throughput screening (HTS); adapted with permission (66), copyright 2022 ELSEVIER (open access). (D) A 3D bioprinted colorectal cancer model derived from patient; adapted with permission (14), copyright 2021 Frontiers.